[go: up one dir, main page]

DE60107900D1 - Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem - Google Patents

Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem

Info

Publication number
DE60107900D1
DE60107900D1 DE60107900T DE60107900T DE60107900D1 DE 60107900 D1 DE60107900 D1 DE 60107900D1 DE 60107900 T DE60107900 T DE 60107900T DE 60107900 T DE60107900 T DE 60107900T DE 60107900 D1 DE60107900 D1 DE 60107900D1
Authority
DE
Germany
Prior art keywords
food
treatment
pharmaceutical composition
cerebral edema
edema
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60107900T
Other languages
English (en)
Other versions
DE60107900T2 (de
Inventor
Hitoo Nishino
Kunio Torii
Hisayuki Uneyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of DE60107900D1 publication Critical patent/DE60107900D1/de
Publication of DE60107900T2 publication Critical patent/DE60107900T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
DE60107900T 2000-04-24 2001-04-24 Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem Expired - Lifetime DE60107900T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US556701 2000-04-24
US09/556,701 US20020119191A1 (en) 2000-04-24 2000-04-24 Pharmaceutical or food composition for treatment or prevention of brain edema

Publications (2)

Publication Number Publication Date
DE60107900D1 true DE60107900D1 (de) 2005-01-27
DE60107900T2 DE60107900T2 (de) 2005-12-15

Family

ID=24222486

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60107900T Expired - Lifetime DE60107900T2 (de) 2000-04-24 2001-04-24 Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem

Country Status (4)

Country Link
US (2) US20020119191A1 (de)
EP (1) EP1161948B1 (de)
JP (1) JP2002020285A (de)
DE (1) DE60107900T2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003230770A1 (en) * 2002-03-28 2003-10-13 Oxis International, Inc. Neuroprotectant methods, compositions, and screening methods thereof
EP1587510A4 (de) * 2003-01-31 2007-08-08 Univ Hong Kong Verfahren zur behandlung von ischämischemschlaganfall mit melatonin
MXPA06009377A (es) * 2004-02-20 2007-03-07 Lifescape Biosciences Inc Composiciones y metodos para regulacion del sueno.
US20100068169A1 (en) * 2007-02-23 2010-03-18 University Of The Witwatersrand, Johannesburg Monolithic drug delivery system
US8750979B2 (en) * 2008-01-29 2014-06-10 St. Jude Medical, AB Method and implantable medical device (IMD) for monitoring permeability status of cell membranes
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
ES2134789T3 (es) * 1991-05-09 1999-10-16 Neurim Pharma 1991 Composiciones que contienen melatonina.
JP3065506B2 (ja) * 1995-04-03 2000-07-17 株式会社資生堂 ピラゾリジン誘導体及びラジカルスカベンジャー、脳梗塞抑制剤、脳浮腫抑制剤
JP3285746B2 (ja) * 1995-11-24 2002-05-27 株式会社資生堂 フェニレンジアミン誘導体及びラジカルスカベンジャー、脳梗塞抑制剤、脳浮腫抑制剤
JP4598203B2 (ja) * 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
US5700828A (en) * 1995-12-07 1997-12-23 Life Resuscitation Technologies, Inc. Treatment or prevention of anoxic or ischemic brain injury with melatonin-containing compositions
US6011019A (en) * 1996-03-12 2000-01-04 University Of South Florida Vasoactive effects and free radical generation by β-amyloid peptides
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
WO1998021947A1 (en) * 1996-11-18 1998-05-28 Internutria, Inc. Compositions and treatment for nighttime persistent reproductive transition symptoms
US5855920A (en) * 1996-12-13 1999-01-05 Chein; Edmund Y. M. Total hormone replacement therapy
KR19980049239A (ko) * 1996-12-19 1998-09-15 윤석모 상치를 이용한 천연멜라토닌함유 식품의 제조방법
CN1164422A (zh) * 1997-05-19 1997-11-12 北京三株工业有限责任公司 一种具有改善睡眠作用的功能食品
US6075045A (en) * 1999-04-28 2000-06-13 Ajinomoto Co., Inc. Method of treating paralysis of the extremities caused by cerebral infarction

Also Published As

Publication number Publication date
US20070098777A1 (en) 2007-05-03
DE60107900T2 (de) 2005-12-15
JP2002020285A (ja) 2002-01-23
EP1161948A2 (de) 2001-12-12
EP1161948A3 (de) 2003-01-08
EP1161948B1 (de) 2004-12-22
US20020119191A1 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ATE551100T1 (de) Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
ATE291438T1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
DE60022916D1 (de) Reboxetin zur Behandlung von peripheren Neuropathien
ATE381347T1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
EP1255765A4 (de) Pharmazeutische zusammensetzung und therapeutische behandlung von rheumatischer arthritis
DE60027290D1 (de) Skleraprothese zur behandlung der weitsichtigkeit und anderer augenkrankheiten
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
ATE416779T1 (de) Arzneimittel mit anemonin als aktivum zur behandlung von aseptischer inflammation
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
ATE296635T1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
ATE431142T1 (de) Arzneimittel zur behandlung und vermeidung neurogener schmerzen
DE60218375D1 (de) Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition